Ex-chiral pool synthesis and receptor binding studies of 4-substituted prolinol derivatives

Tetrahedron Asymmetry

Volumn 14, Issue 20, 2003, Pages 3141-3152

  Heindl, Cornelia ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (N ACETYL N METHYLAMINO) N (1 BENZYL 5 HYDROXYMETHYL 3 PYRROLIDINYL) 5 CHLORO 2 METHOXYBENZAMIDE; 4 ACETYLAMINO N (1 BENZYL 5 HYDROXYMETHYL 3 PYRROLIDINYL) 5 CHLORO 2 METHOXYBENZAMIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAMIDE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; HYDROXYPROLINE; KETANSERIN; N (1 BENZYL 5 HYDROXYMETHYL 3 PYRROLIDINYL) 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; N (1 BENZYL 5 HYDROXYMETHYL 4 PYRROLIDINYL) 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; PROLINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SPIPERONE; SULPIRIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CHIRALITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EPIMERIZATION; ESTERIFICATION; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOCHEMISTRY; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; SYNTHESIS;

EID: 1642300673     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetasy.2003.08.019     Document Type: Article

References (39)

1. Iwanami S., Takashima M., Hirata Y., Hasegawa O., Usuda S. J. Med. Chem. 24:1981;1224.
2. Mishra R.K., Chiu S., Chiu P., Mishra C.P. Methods Find. Exp. Clin. Pharmacol. 5:1983;203.
3. Thomas C., Hübner H., Gmeiner P. Bioorg. Med. Chem. Lett. 9:1999;841.
4. Ohmori J., Maeno K., Hidaka K., Nakato K., Matsumoto M., Tada S., Hattori H., Sakamoto S., Tsukamoto S., Usuda S., Mase T. J. Med. Chem. 39:1996;2764.
5. Nagle A.S., Salvatore R.N., Chong B.-D., Jung K.W. Tetrahedron Lett. 41:2000;3011.
6. Tanaka K., Sawanishi H. Tetrahedron: Asymmetry. 6:1995;1641.
7. Cossy J., Dumas C., Michel P., Gomez Pardo D. Tetrahedron Lett. 36:1995;549.
8. Yanagi T., Katajima A., Anzai K., Kodama K., Mizoguchi J.-I., Fujiwara H., Sakiyama H., Kamoda O., Kamei C. Chem. Pharm. Bull. 47:1999;1650.
9. Braish T.F., Fox D.E. J. Org. Chem. 55:1990;1684.
10. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin A.R. J. Med. Chem. 34:1991;717.
11. Peterson M.L., Vince R. J. Med. Chem. 34:1991;2787.
12. Bouzard D., Di Cesare P., Essiz M., Jacquet J.P., Kiechel J.R., Remuzon P., Weber A., Oki T., Masuyoshi M., Kessler R.E., Fung-Tomc J., Desiderio J. J. Med. Chem. 33:1990;1344.
13. Baker G.L., Fritschel S.J., Stille J.R., Stille J.K. J. Org. Chem. 46:1981;2954.
14. Remuzon P., Bouzard D., Guiol C., Jacquet J.P. J. Med. Chem. 35:1992;2898.
15. Greenstein J.P. J. Biolog. Chem. 204:1953;307.
16. Greenstein J.P. J. Biolog. Chem. 195:1952;383.
17. Rosen T., Fesik S.W., Chu D.T.W., Pernet A.G. Synthesis. 1988;40.
18. Rosen T., Chu D.T.W., Lico I.M., Fernandes P.B., Marsh K., Shen L., Cepa V.G., Pernet A.G. J. Med. Chem. 31:1988;1598.
19. Takahata H., Takamatsu T., Chen Y., Ohkubo N., Yamazaki T., Momose T., Date T. J. Org. Chem. 55:1990;3792.
20. Monn J.A., Valli M.J., True R.A., Schoepp D.D., Leander J.D., Lodge D. Bioorg. Med. Chem. Lett. 3:1993;95.
21. Smith E.M., Swiss G.F., Neustadt B.R., Gold E.H., Sommer J.A., Brown A.D., Chiu P.J.S., Moran R., Sybertz E.J., Baum T. J. Med. Chem. 31:1988;875.
22. Gmeiner P., Kärtner A. Synthesis. 1995;83.
23. Gmeiner P., Kärtner A., Junge D. Tetrahedron Lett. 34:1993;4325.
24. Watanabe K., Fukumura T., Sasaki S., Maeda M., Takehara S. Chem. Pharm. Bull. 39:1991;3211.
25. Gmeiner P., Junge D., Kärtner A. J. Org. Chem. 59:1994;6766.
26. Sawanishi H., Myamoto K., Tanaka K., Suzuki K. Jpn. Kokai Tokkyo Koho. 1993;40.
27. Gilbertson S.R., Pawlick R.V. Angew. Chem., Int. Ed. 35:1996;902.
28. Williams M.A., Rapoport H. J. Org. Chem. 59:1994;3616.
29. Seno K., Ohtani M., Watanabe F. PCT Int. Appl. 1998;178.
30. Thomas, C. Dissertation, Bonn, 1997.
31. Moriarty K.J., Shimshock Y., Ahmed G., Wu J., Wen J., Li W., Erickson S.D., Letourneau J.J., McDonald E., Leftheris K., Wrobleski S.T. PCT Int. Appl. 2001;123.
32. Arakawa Y., Yasuda M., Ohnishi M., Yoshifuji S. Chem. Pharm. Bull. 45:1997;255.
33. Hayes G., Biden T.J., Selbie L.A., Shine J. J. Mol. Endocrinol. 6:1992;920.
34. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M.-P., Giros B., Schwartz J.-C. Eur. J. Pharmacol. 225:1992;331.
35. Asghari V.S., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H.M. J. Neurochem. 65:1995;1157.
36. Hübner H., Haubmann C., Utz W., Gmeiner P. J. Med. Chem. 43:2000;756. and references cited therein.
37. Millan M.J. J. Pharmacol. Exp. Ther. 295:2000;853.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265.
39. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.